Equillium (EQ) Current Deferred Revenue (2022 - 2024)
Equillium (EQ) posted quarterly Current Deferred Revenue of $2.1 million for Q3 2024, down 86.94% year-over-year from $15.8 million in Q4 2023, and down 75.47% quarter-over-quarter from $8.4 million in Q2 2024.
Equillium (EQ) Current Deferred Revenue (2022 - 2024) Analysis & Trends
Equillium (EQ) has reported Current Deferred Revenue for 3 consecutive years, with $2.1 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Current Deferred Revenue fell 86.94% year-over-year to $2.1 million; the TTM figure through Sep 2024 stood at $2.1 million (down 86.94% YoY), while the FY2023 annual figure was $15.7 million, up 7.0% from the prior year.
- Current Deferred Revenue declined to $2.1 million in Q3 2024 per EQ's latest filing, from $8.4 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $15.8 million in Q3 2023 and bottomed at $2.1 million in Q3 2024.
- Historically, Current Deferred Revenue has averaged $12.4 million across 3 years, with a median of $14.5 million in 2022.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue grew 7.0% — and 2024, when it sank 86.94%.
- Equillium's Current Deferred Revenue stood at $14.7 million in 2022, then advanced by 7.0% to $15.7 million in 2023, then tumbled by 86.85% to $2.1 million in 2024.
- Business Quant data shows EQ's Current Deferred Revenue at $2.1 million in Q3 2024, $8.4 million in Q2 2024, and $13.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 8.43 Mn |
| Mar 31, 2024 | 13.36 Mn |
| Dec 31, 2023 | 15.73 Mn |
| Sep 30, 2023 | 15.83 Mn |
| Jun 30, 2023 | 14.24 Mn |
| Mar 31, 2023 | 14.77 Mn |
| Dec 31, 2022 | 14.70 Mn |